Scarica l'app Stockscreener
16.07
2.19%
-0.36
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CSTL Giù?
Forum
Previsione
Castle Biosciences Inc Borsa (CSTL) Ultime notizie
Cerity Partners LLC Buys Shares of 21,138 Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World
Castle Biosciences’ Founder, President and CEO Derek - GlobeNewswire
Castle Biosciences stock jumps after FDA grants Breakthrough Device status to melanoma test - MSN
Why Castle Biosciences Inc. stock is on top investor watchlistsSkyrocketing returns - jammulinksnews.com
Castle Biosciences CEO Wins Top Houston Leadership Award for Pioneering Cancer Diagnostics - Stock Titan
Castle Biosciences, Revolution Medicines get FDA breakthrough statuses - MSN
Leerink Partnrs Has Pessimistic View of CSTL Q2 Earnings - Defense World
What drives Castle Biosciences Inc. stock priceRapidly expanding wealth - Autocar Professional
What analysts say about Castle Biosciences Inc. stockSkyrocketing investment returns - Autocar Professional
Castle Biosciences stock jumps after FDA grants Breakthrough Device status - Investing.com India
FDA Grants Breakthrough Status to Melanoma Test - Conexiant
FDA grants breakthrough device status to Castle Biosciences’ melanoma test - Investing.com
FDA Grants Breakthrough Device Designation to Castle Biosciences’ DecisionDx®-Melanoma Test - GlobeNewswire
FDA Breakthrough: Castle Biosciences' New Melanoma Test Could Transform Cancer Diagnosis - Stock Titan
New York State Common Retirement Fund Has $3.27 Million Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World
Castle Biosciences Inc. Stock Analysis and ForecastAccelerated financial growth - Autocar Professional
Is Castle Biosciences Inc. a good long term investmentHigh-margin investment plays - jammulinksnews.com
Teacher Retirement System of Texas Grows Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World
Stephens Inc. AR Has $273,000 Stake in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World
Castle Biosciences Achieves Multiple Awards Recognizing Workplace Excellence in 2025 Top Workplaces Program - Quiver Quantitative
Castle Biosciences earns multiple Top Workplaces awards, including national Healthcare Industry award. - AInvest
Castle Biosciences Honored with Multiple Top Workplaces Awards Recognizing the Company’s Strong Culture - GlobeNewswire
Castle Biosciences Dominates Healthcare Workplace Rankings with 7 Major Awards and #3 Industry Position - Stock Titan
How Castle Biosciences Inc. stock performs during market volatilityTop Rated Trade Entries - Newser
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Castle Biosciences to Release Q2 2025 Financial Results and Host Conference Call on Aug. 4 - AInvest
Why Castle Biosciences Inc. stock attracts strong analyst attentionEarly Buy Suggestion - Newser
What makes Castle Biosciences Inc. stock price move sharplyProven Trading Plan - Newser
Castle Biosciences' Q2 Results: Diagnostic Innovation Fuels Growth Amid Profit Challenges - AInvest
Castle Biosciences, Inc. to Release Second Quarter Financial Results on August 4, 2025 - Nasdaq
Castle Biosciences to Release Second Quarter 2025 Financial - GlobeNewswire
Castle Biosciences Sets Q2 2025 Earnings Date: Key Financial Results Coming August 4 - Stock Titan
Allspring Global Investments Holdings LLC Raises Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World
Castle Biosciences, Inc.(NasdaqGM: CSTL) dropped from Russell 2500 Growth Index - MarketScreener
Is Castle Biosciences (NASDAQ:CSTL) Using Too Much Debt? - 富途牛牛
1.50%
1.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):